Tonix Pharmaceuticals (NASDAQ:TNXP) Rating Lowered to Sell at Wall Street Zen
Wall Street Zen downgraded shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) from a hold rating to a sell rating in a report issued on Friday. Separately, Noble Financial reiterated an “outperform” rating and issued a $70.00 target price on shares of Tonix Pharmaceuticals in a research note on Thursday, March 20th. View Our Latest […]
Wall Street Zen downgraded shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) from a hold rating to a sell rating in a report issued on Friday. Separately, Noble Financial reiterated an “outperform” rating and issued a $70.00 target price on shares of Tonix Pharmaceuticals in a research note on Thursday, March 20th. View Our Latest […]
